EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Therapeutic Antibodies in Medicine

Prerna Sharma iD, Rahul V Joshi iD, Robert Pritchard iD, Kevin Xu, Maya A Eicher iD

Molecules · 05.09.2023 · 28 (18) · 6438

DOI: 10.3390/molecules28186438 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecules, online erschienen am 05.09.2023. Verfasst von Prerna Sharma und 4 weiteren Autor:innen. Beteiligte Einrichtung: Geisinger Commonwealth School of Medicine, Scranton, PA 18509, USA. Hauptthemen laut MEDLINE: Medicine, Autoimmune Diseases, Biological Products. Die Arbeit wurde bisher 78-mal zitiert (Crossref) und nennt 440 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Antibody engineering has developed into a wide-reaching field, impacting a multitude of industries, most notably healthcare and diagnostics. The seminal work on developing the first monoclonal antibody four decades ago has witnessed exponential growth in the last 10–15 years, where regulators have approved monoclonal antibodies as therapeutics and for several diagnostic applications, including the remarkable attention it garnered during the pandemic. In recent years, antibodies have become the fastest-growing class of biological drugs approved for the treatment of a wide range of diseases, from cancer to autoimmune conditions. This review discusses the field of therapeutic antibodies as it stands today. It summarizes and outlines the clinical relevance and application of therapeutic antibodies in treating a landscape of diseases in different disciplines of medicine. It discusses the nomenclature, various approaches to antibody therapies, and the evolution of antibody therapeutics. It also discusses the risk profile and adverse immune reactions associated with the antibodies and sheds light on future applications and perspectives in antibody drug discovery.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MedicineAutoimmune DiseasesBiological ProductsHumansAntibodies, MonoclonalClinical Relevance

Stichwörter der Autor:innen

drug developmentdrug discoverymedicineprotein engineeringtherapeutic antibodies

Substanzen

Antibodies, MonoclonalBiological Products

Autor:innen und Institutionen

  • Geisinger Commonwealth School of Medicine, Scranton, PA 18509, USA.

ORCID-Profile: Prerna Sharma, Rahul V Joshi, Robert Pritchard, Maya A Eicher

Zitieren

APA

Sharma, P., Joshi, R. V., Pritchard, R., Xu, K., & Eicher, M. A. (2023). Therapeutic Antibodies in Medicine. Molecules, 28(18), 6438. https://doi.org/10.3390/molecules28186438

Vancouver

Sharma P, Joshi RV, Pritchard R, Xu K, Eicher MA. Therapeutic Antibodies in Medicine. Molecules. 2023;28(18):6438. doi:10.3390/molecules28186438

BibTeX
@article{Sharma2023,
  author = {Sharma, Prerna and Joshi, Rahul V and Pritchard, Robert and Xu, Kevin and Eicher, Maya A},
  title = {Therapeutic Antibodies in Medicine},
  journal = {Molecules},
  year = {2023},
  volume = {28},
  number = {18},
  pages = {6438},
  doi = {10.3390/molecules28186438}
}
Kostenlos starten →